Skip to content
Screener

Replimune Group REPL Q4 2025 Annual earnings

Reported May 22, 2025 · Before market open

Revenue$1.5M
EPS-$0.82Miss by $0.07
EPS estimate-$0.75

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$1.0M
EPS estimate-$0.75

Financials

Q4 2025

Income statement

See full
Operating income-$79.3M-35.0%
Net income-$74.1M-34.6%
EPS (diluted)-$0.820.0%

Balance sheet

See full
Cash & equivalents$112.8M+48.1%
Total debt$79.0M+0.5%
Total equity$415.8M+11.0%
Total assets$551.3M+13.0%

Cash flow

See full
Operating cash flow-$53.7M-16.4%
CapEx$1.1M-34.8%
Free cash flow-$54.9M-14.5%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$750.89M+37.9%
Enterprise value$717.04M+31.1%

Returns & leverage

See full
Return on equity-62.6%+33.4pp
Debt / equity0.2×0.0×
Current ratio8×-2.8×

FAQ

When did Replimune Group report Q4 2025 earnings?
Replimune Group (REPL) reported Q4 2025 earnings on May 22, 2025 before market open.
What were Replimune Group's Q4 2025 revenue and EPS?
Replimune Group reported revenue of $1.5M and eps of $-0.82 for Q4 2025.
Did Replimune Group beat estimates in Q4 2025?
EPS missed the consensus estimate of $-0.75 by $0.07.
How did Replimune Group's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 63.6% from $4.0M a year earlier and eps grew 0.0% from $-0.82.
Where can I find Replimune Group's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-051847) and the 10-K periodic report (0001737953-25-000009) directly on SEC EDGAR. The filing index links above go to sec.gov.